143 related articles for article (PubMed ID: 19903812)
21. HIV-1 gp120 determinants proximal to the CD4 binding site shift protective glycans that are targeted by monoclonal antibody 2G12.
Duenas-Decamp MJ; Clapham PR
J Virol; 2010 Sep; 84(18):9608-12. PubMed ID: 20610714
[TBL] [Abstract][Full Text] [Related]
22. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
23. Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.
Marradi M; Di Gianvincenzo P; Enríquez-Navas PM; Martínez-Ávila OM; Chiodo F; Yuste E; Angulo J; Penadés S
J Mol Biol; 2011 Jul; 410(5):798-810. PubMed ID: 21440555
[TBL] [Abstract][Full Text] [Related]
24. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design.
Wang LX; Ni J; Singh S; Li H
Chem Biol; 2004 Jan; 11(1):127-34. PubMed ID: 15113002
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy.
Martines E; García I; Marradi M; Padro D; Penadés S
Langmuir; 2012 Dec; 28(51):17726-32. PubMed ID: 23198686
[TBL] [Abstract][Full Text] [Related]
26. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
27. Antibody responses to the HIV-1 envelope high mannose patch.
Daniels CN; Saunders KO
Adv Immunol; 2019; 143():11-73. PubMed ID: 31607367
[TBL] [Abstract][Full Text] [Related]
28. Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.
Pan R; Qin Y; Banasik M; Lees W; Shepherd AJ; Cho MW; Kong XP
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343576
[TBL] [Abstract][Full Text] [Related]
29. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
J Virol; 2017 May; 91(9):. PubMed ID: 28202756
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12.
Wu Y; West AP; Kim HJ; Thornton ME; Ward AB; Bjorkman PJ
Cell Rep; 2013 Dec; 5(5):1443-55. PubMed ID: 24316082
[TBL] [Abstract][Full Text] [Related]
31. Polyepitope protein incorporated the HIV-1 mimotope recognized by monoclonal antibody 2G12.
Karpenko LI; Scherbakova NS; Chikaev AN; Tumanova OY; Lebedev LR; Shalamova LA; Pyankova OG; Ryzhikov AB; Ilyichev AA
Mol Immunol; 2012 Apr; 50(4):193-9. PubMed ID: 22341130
[TBL] [Abstract][Full Text] [Related]
32. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
Trkola A; Purtscher M; Muster T; Ballaun C; Buchacher A; Sullivan N; Srinivasan K; Sodroski J; Moore JP; Katinger H
J Virol; 1996 Feb; 70(2):1100-8. PubMed ID: 8551569
[TBL] [Abstract][Full Text] [Related]
33. The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12.
Chaillon A; Braibant M; Moreau T; Thenin S; Moreau A; Autran B; Barin F
J Virol; 2011 Apr; 85(7):3642-8. PubMed ID: 21248038
[TBL] [Abstract][Full Text] [Related]
34. Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.
Agrawal-Gamse C; Luallen RJ; Liu B; Fu H; Lee FH; Geng Y; Doms RW
J Virol; 2011 Jan; 85(1):470-80. PubMed ID: 20962094
[TBL] [Abstract][Full Text] [Related]
35. A cryptic polyreactive antibody recognizes distinct clades of HIV-1 glycoprotein 120 by an identical binding mechanism.
Dimitrov JD; Planchais C; Scheel T; Ohayon D; Mesnage S; Berek C; Kaveri SV; Lacroix-Desmazes S
J Biol Chem; 2014 Jun; 289(25):17767-79. PubMed ID: 24802758
[TBL] [Abstract][Full Text] [Related]
36. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
37. N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function.
Pancera M; Yang Y; Louder MK; Gorman J; Lu G; McLellan JS; Stuckey J; Zhu J; Burton DR; Koff WC; Mascola JR; Kwong PD
PLoS One; 2013; 8(2):e55701. PubMed ID: 23431362
[TBL] [Abstract][Full Text] [Related]
38. Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5).
Joos B; Trkola A; Kuster H; Aceto L; Fischer M; Stiegler G; Armbruster C; Vcelar B; Katinger H; Günthard HF
Antimicrob Agents Chemother; 2006 May; 50(5):1773-9. PubMed ID: 16641449
[TBL] [Abstract][Full Text] [Related]
39. Transplanting supersites of HIV-1 vulnerability.
Zhou T; Zhu J; Yang Y; Gorman J; Ofek G; Srivatsan S; Druz A; Lees CR; Lu G; Soto C; Stuckey J; Burton DR; Koff WC; Connors M; Kwong PD
PLoS One; 2014; 9(7):e99881. PubMed ID: 24992528
[TBL] [Abstract][Full Text] [Related]
40. Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM.
Chromikova V; Mader A; Hofbauer S; Göbl C; Madl T; Gach JS; Bauernfried S; Furtmüller PG; Forthal DN; Mach L; Obinger C; Kunert R
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1536-44. PubMed ID: 25748881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
